Clinical Trials List
Protocol NumberCVAY736O12301
Completed
2023-04-01 - 2029-02-20
Phase III
Not yet recruiting1
ICD-10D59.0
Drug-induced autoimmune hemolytic anemia
ICD-10D59.1
Other autoimmune hemolytic anemias
ICD-9283.0
Autoimmune hemolytic anemias
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ming-Chung Kao Division of Hematology & Oncology
- Jin-Hou Wu 無
- Tung-Liang Lin Division of Hematology & Oncology
- 高小雯 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
90 participants
